Search
Cidara Therapeutics Inc
CDTXAdd to Watchlist
221.380USD
0.0000.00%
Close 06/26, 16:00（ET）Quotes delayed by 15 min
6.96BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-01-06The current earnings forecast score of Cidara Therapeutics Inc is 6.75, ranking 332 out of 399 in the Biotechnology & Medical Research industry. The average price target is 221.50, with a high of 221.50 and a low of 199.00.
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Cidara Therapeutics Inc's price target?
Analysts forecast that Cidara Therapeutics Inc's price target is USD 221.50, with the highest forecast at USD 221.50 and the lowest forecast at USD 199.00.
How have Cidara Therapeutics IncCDTX's recent earnings per share performed?
The market expectation was USD -3.10, while Cidara Therapeutics IncCDTX's earnings per share (EPS) for the previous quarter was USD -1.65. EPS for the next quarter is expected at USD -1.51.
